Cyprus vs Malta: The number of people with susceptibility test result for rifampicin
Cyprus
29
in 2021
Malta
27
in 2021
Cyprus rank
128th
Malta rank
129th
The number of people with susceptibility test result for rifampicin over time
- Cyprus
- Malta
How they compare
Cyprus currently reports 29 against 27 in Malta, a difference of 2.
That makes Cyprus's figure about 1.1 times Malta's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Cyprus ahead.
Cyprus ranks 128th and Malta ranks 129th of 155 countries.
Across the 2 decades both report, Cyprus averaged higher in 1 and Malta in 1.
Head to head by decade
| Decade | Cyprus | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 37.67 | 29 | 8.67 | Cyprus |
| 2020s | 27 | 30.5 | 3.5 | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cyprus or Malta?
- Cyprus, at 29 against 27 in Malta as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cyprus and Malta?
- 2, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Malta?
- 5 years are reported by both, from 2017 to 2021.
- How do Cyprus and Malta rank globally for the number of people with susceptibility test result for rifampicin?
- Cyprus ranks 128th and Malta ranks 129th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.